Cart
sales@molnova.com
3BDO
CAS No. 890405-51-3
3BDO( —— )
Catalog No. M26592 CAS No. 890405-51-3
3BDO is a new mTOR activator. 3BDO inhibits autophagy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 65 | In Stock |
|
| 2MG | 37 | In Stock |
|
| 5MG | 59 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 206 | In Stock |
|
| 50MG | 323 | In Stock |
|
| 100MG | 483 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3BDO
-
NoteResearch use only, not for human use.
-
Brief Description3BDO is a new mTOR activator. 3BDO inhibits autophagy.
-
Description3BDO is a new mTOR activator. 3BDO inhibits autophagy.(In Vitro):Adiminstration of 3BDO could dose- and time-dependently decrease FLJ11812 level in HUVECs. Overexpression of FLJ11812 reverses the inhibition of autophagy induced by 3BDO.Adiminstration of 3BDO suppresses the increase in MAP1LC3B puncta induced with rapamycin and it also inhibits the effect of rapamycin in HUVECs. Rapamycin fails to decrease the phosphorylation of MTOR and RPS6KB1 in the presence of 3BDO. The phosphorylation of Ser residues is decreased in HUVECs treated with 10 μM rapamycin, and 60 μM 3BDO reverses the phosphorylation. Adiminstration of 3BDO suppresses the increased MAP1LC3B puncta number, MAP1LC3B-II level and decreased SQSTM1 protein level induced by rapamycin.(In Vivo):Administration of 3BDO increased p-p70S6K levels and decreased ATG13 protein levels in mouse plaque endothelium. Administration of 3BDO stabilizes established atherosclerotic lesions in apoE-/- mice. In apoE-/- mice, serum IL-6 and IL-8 levels were significantly reduced after administration of 3BDO compared to controls . Compared to controls, apoE-/- mice were shown to inhibit endothelial autophagy and apoptosis when administered with 3BDO, thus 3BDO prevents endothelial damage in atherosclerosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number890405-51-3
-
Formula Weight327.336
-
Molecular FormulaC18H17NO5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (305.50 mM)
-
SMILES[O-][N+](=O)c1ccccc1OCC1CC(Cc2ccccc2)C(=O)O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jutiviboonsuk A, et, al. Bioactive constituents from roots of Bursera tonkinensis. Phytochemistry. 2005 Dec;66(23):2745-51.
molnova catalog
related products
-
Benzyl selenocyanate
Benzyl selenocyanate is a chemopreventive agent that effectively inhibits chemically induced tumors at both initiation and postinitiation stages in animal models.
-
Clovamide
Trans-Clovamide is a naturally occurring caffeoyl conjugate identified in the antioxidant polyphenolic fraction of cocoa (T. cacao L.) Trans-Clovamide is a potent antioxidantand that has shown neuroprotective effects (EC50s = 0.9-3.7 μM) in several in vitro models of neuronal death.
-
TL02-59
TL02-59 is a selective inhibitor of Fgr in Src-family kinase (IC50 = 0.03 nM). TL02-59 inhibits Lyn and Hck with IC50s of 0.1 nM and 160 nM, respectively.
